While NRF2 generally counteracts the pro-inflammatory effects of NF-κB, dysregulation of this crosstalk contributes to the pathogenesis of chronic inflammatory diseases, cancer, and neurodegenerative disorders. The gene discussed is NFKB1; the disease is cancer.